IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$506.74 USD
-10.32 (-2.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $506.63 -0.11 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for IDEXX Laboratories, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 845.04 | 679.09 | 744.84 | 582.13 | 427.79 |
Depreciation/Amortization & Depletion | 114.91 | 111.90 | 104.60 | 96.00 | 88.01 |
Net Change from Assets/Liabilities | -72.43 | -273.53 | -137.52 | -31.76 | -104.97 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 18.99 | 25.53 | 43.63 | 1.70 | 48.32 |
Net Cash From Operating Activities | 906.51 | 542.98 | 755.55 | 648.06 | 459.16 |
Property & Equipment | -133.63 | -148.84 | -119.55 | -106.96 | -154.97 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -11.51 | -173.42 | -1.50 | -50.30 |
Investments | 8.38 | -25.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -10.00 | 0.00 | -0.92 | -0.26 |
Net Cash from Investing Activities | -125.25 | -195.35 | -292.97 | -109.38 | -205.53 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -34.86 | -794.57 | -715.77 | -152.09 | -273.61 |
Issuance (Repayment) of Debt | -75.00 | -75.00 | -50.00 | 200.00 | 100.00 |
Increase (Decrease) Short-Term Debt | -329.00 | 505.50 | 73.50 | -289.63 | -110.28 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.14 | -6.87 | -5.14 | -6.70 | -2.53 |
Net Cash from Financing Activities | -442.00 | -370.94 | -697.41 | -248.42 | -286.41 |
Effect of Exchange Rate Changes | 2.13 | -8.61 | -4.64 | 3.33 | -0.69 |
Net Change In Cash & Equivalents | 341.39 | -31.91 | -239.47 | 293.60 | -33.47 |
Cash at Beginning of Period | 112.55 | 144.45 | 383.93 | 90.33 | 123.79 |
Cash at End of Period | 453.93 | 112.55 | 144.45 | 383.93 | 90.33 |
Diluted Net EPS | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 |
Fiscal Year End for IDEXX Laboratories, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 438.88 | 235.58 | 845.04 | 650.52 | 438.29 |
Depreciation/Amortization & Depletion | 62.10 | 29.90 | 114.91 | 85.17 | 56.19 |
Net Change from Assets/Liabilities | -67.13 | -81.42 | -72.43 | -114.25 | -130.31 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.06 | 14.52 | 18.99 | 35.22 | 20.06 |
Net Cash From Operating Activities | 446.90 | 198.59 | 906.51 | 656.66 | 384.23 |
Property & Equipment | -63.58 | -30.27 | -133.63 | -101.08 | -66.98 |
Acquisition/ Disposition of Subsidiaries | -77.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.73 | 0.33 | 8.38 | 6.26 | 0.00 |
Other Investing Activities | 0.00 | -77.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -139.85 | -106.94 | -125.25 | -94.82 | -66.98 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -354.31 | -144.07 | -34.86 | -44.98 | -9.68 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -75.00 | 0.00 | 6.26 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -329.00 | -329.00 | -315.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -3.14 | 33.83 | 21.31 |
Net Cash from Financing Activities | -354.31 | -144.07 | -442.00 | -340.15 | -297.11 |
Effect of Exchange Rate Changes | -5.08 | -4.07 | 2.13 | -2.54 | 0.16 |
Net Change In Cash & Equivalents | -52.34 | -56.50 | 341.39 | 219.15 | 20.29 |
Cash at Beginning of Period | 453.93 | 453.93 | 112.55 | 112.55 | 112.55 |
Cash at End of Period | 401.59 | 397.43 | 453.93 | 331.70 | 132.84 |
Diluted Net EPS | 2.44 | 2.81 | 2.31 | 2.53 | 2.67 |